目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Disease Outlook
1.2.2. Regional Scope
1.2.3. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Disease Outlook
2.2.2. Regional outlook
2.3. Competitive Insights

Chapter 3. Enteric Diseases Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Enteric Diseases Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis

Chapter 4. Enteric Diseases Testing: Disease Estimates & Trend Analysis
4.1. Disease Segment Dashboard
4.2. Enteric Diseases Testing Market: Industry Movement Analysis
4.3. Global Enteric Diseases Testing Market Size & Trend Analysis, by Disease , 2018 to 2030 (USD Million)
4.4. Bacterial
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. C. Difficile
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Campylobacteriosis
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Cholera
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. E. Coli
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. H. Pylori
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Salmonellosis
4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.8. Shigellosis
4.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Viral
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Rotavirus
4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Norovirus
4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Parasitic
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Amebiasis
4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Cryptosporidiosis
4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Giardiasis
4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Enteric Diseases Testing Market: Regional Estimates & Trend Analysis
5.1. Regional Market Dashboard
5.2. Regional Market Share Analysis, 2024 & 2030
5.3. Continuous bioprocessing market by Region: Key Takeaways
5.4. North America
5.4.1. U.S.
5.4.1.1. Key country dynamics
5.4.1.2. Regulatory framework/ reimbursement structure
5.4.1.3. Competitive scenario
5.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Canada
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Mexico
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Europe
5.5.1. UK
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
5.5.2. Germany
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
5.5.3. France
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
5.5.4. Italy
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
5.5.5. Spain
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
5.5.6. Norway
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
5.5.7. Sweden
5.5.7.1. Key country dynamics
5.5.7.2. Regulatory framework/ reimbursement structure
5.5.7.3. Competitive scenario
5.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
5.5.8. Denmark
5.5.8.1. Key country dynamics
5.5.8.2. Regulatory framework/ reimbursement structure
5.5.8.3. Competitive scenario
5.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Asia Pacific
5.6.1. Japan
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
5.6.2. China
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
5.6.3. India
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
5.6.4. Australia
5.6.4.1. Key country dynamics
5.6.4.2. Regulatory framework/ reimbursement structure
5.6.4.3. Competitive scenario
5.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
5.6.5. South Korea
5.6.5.1. Key country dynamics
5.6.5.2. Regulatory framework/ reimbursement structure
5.6.5.3. Competitive scenario
5.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
5.6.6. Thailand
5.6.6.1. Key country dynamics
5.6.6.2. Regulatory framework/ reimbursement structure
5.6.6.3. Competitive scenario
5.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Latin America
5.7.1. Brazil
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
5.7.2. Argentina
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
5.8. MEA
5.8.1. South Africa
5.8.1.1. Key country dynamics
5.8.1.2. Regulatory framework/ reimbursement structure
5.8.1.3. Competitive scenario
5.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
5.8.2. Saudi Arabia
5.8.2.1. Key country dynamics
5.8.2.2. Regulatory framework/ reimbursement structure
5.8.2.3. Competitive scenario
5.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
5.8.3. UAE
5.8.3.1. Key country dynamics
5.8.3.2. Regulatory framework/ reimbursement structure
5.8.3.3. Competitive scenario
5.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
5.8.4. Kuwait
5.8.4.1. Key country dynamics
5.8.4.2. Regulatory framework/ reimbursement structure
5.8.4.3. Competitive scenario
5.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. Key company heat map analysis, 2024
6.4. Company Profiles
6.4.1. Abbott
6.4.1.1. Company overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. BD
6.4.2.1. Company overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Biomerica
6.4.3.1. Company overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. BIOMÉRIEUX
6.4.4.1. Company overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. Bio-Rad Laboratories, Inc.
6.4.5.1. Company overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. Cepheid
6.4.6.1. Company overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
6.4.7. Coris Bioconcept
6.4.7.1. Company overview
6.4.7.2. Financial performance
6.4.7.3. Product benchmarking
6.4.7.4. Strategic initiatives
6.4.8. DiaSorin S.p.A.
6.4.8.1. Company overview
6.4.8.2. Financial performance
6.4.8.3. Product benchmarking
6.4.8.4. Strategic initiatives
6.4.9. Meridian Bioscience
6.4.9.1. Company overview
6.4.9.2. Financial performance
6.4.9.3. Product benchmarking
6.4.9.4. Strategic initiatives
6.4.10. Quest Diagnostics Incorporated
6.4.10.1. Company overview
6.4.10.2. Financial performance
6.4.10.3. Product benchmarking
6.4.10.4. Strategic initiatives

List of Tables
Table 1 List of abbreviations
Table 2 North America enteric disease testing market, by country, 2018 - 2030 (USD Million)
Table 3 North America enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 4 U.S. enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 5 Canada enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 6 Mexico enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 7 Europe enteric disease testing market, by country, 2018 - 2030 (USD Million)
Table 8 Europe enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 9 UK enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 10 Germany enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 11 France enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 12 Italy enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 13 Spain enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 14 Denmark enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 15 Sweden enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 16 Norway enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 17 Asia Pacific enteric disease testing market, by country, 2018 - 2030 (USD Million)
Table 18 Asia Pacific enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 19 China enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 20 Japan enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 21 India enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 22 Australia enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 23 South Korea enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 24 Thailand enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 25 Latin America enteric disease testing market, by country, 2018 - 2030 (USD Million)
Table 26 Latin America enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 27 Brazil enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 28 Argentina enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 29 Middle East & Africa enteric disease testing market, by country, 2018 - 2030 (USD Million)
Table 30 Middle East & Africa enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 31 South Africa enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 33 UAE enteric disease testing market, by disease, 2018 - 2030 (USD Million)
Table 34 Kuwait enteric disease testing market, by disease, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Enteric disease testing market: market outlook
Fig. 10 Enteric disease competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Enteric disease testing market driver impact
Fig. 16 Enteric disease testing market restraint impact
Fig. 17 Enteric disease testing market strategic initiatives analysis
Fig. 18 Global enteric disease testing market: Disease movement analysis
Fig. 19 Global enteric disease testing market: Disease outlook and key takeaways
Fig. 20 Bacterial enteric disease testing market estimates and forecast, 2018 - 2030
Fig. 21 Viral enteric disease testing market estimates and forecast, 2018 - 2030
Fig. 22 Rotavirus testing market estimates and forecast, 2018 - 2030
Fig. 23 Norovirus testing market estimates and forecast, 2018 - 2030
Fig. 24 Parasitic enteric disease testing market estimates and forecast, 2018-203
Fig. 25 Global enteric disease testing market: Regional movement analysis
Fig. 26 Global enteric disease testing market: Regional outlook and key takeaways
Fig. 27 North America enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 28 U.S. enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 29 Canada enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 30 Mexico enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 31 Europe enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 32 UK enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 33 Germany enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 34 France enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 35 Italy enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 36 Spain enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 37 Denmark enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 38 Sweden enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 39 Norway enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 40 Asia Pacific enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 41 China enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 42 Japan enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 43 India enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 44 Thailand enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 45 South Korea enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 46 Australia enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 47 Latin America enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 48 Brazil enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 49 Argentina enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 50 Middle East and Africa enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 51 South Africa enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 52 Saudi Arabia enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 53 UAE enteric disease testing market estimates and forecasts, 2018 - 2030
Fig. 54 Kuwait enteric disease testing market estimates and forecasts, 2018 - 2030